BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36809290)

  • 1. Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.
    Hennigan RF; Thomson CS; Stachowski K; Nassar N; Ratner N
    PLoS One; 2023; 18(2):e0281876. PubMed ID: 36809290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence resonance energy transfer analysis of merlin conformational changes.
    Hennigan RF; Foster LA; Chaiken MF; Mani T; Gomes MM; Herr AB; Ip W
    Mol Cell Biol; 2010 Jan; 30(1):54-67. PubMed ID: 19884346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
    Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
    Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of the FERM and C-terminal domain complex of Drosophila Merlin.
    Zhang F; Liu B; Gao Y; Long J; Zhou H
    Biochem Biophys Res Commun; 2021 May; 553():92-98. PubMed ID: 33765559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
    Lallemand D; Saint-Amaux AL; Giovannini M
    J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the binding of Merlin FERM domain to the E3 ubiquitin ligase substrate adaptor DCAF1.
    Li Y; Wei Z; Zhang J; Yang Z; Zhang M
    J Biol Chem; 2014 May; 289(21):14674-81. PubMed ID: 24706749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
    Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
    J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.
    Mani T; Hennigan RF; Foster LA; Conrady DG; Herr AB; Ip W
    Mol Cell Biol; 2011 May; 31(10):1983-96. PubMed ID: 21402777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational flexibility determines the Nf2/merlin tumor suppressor functions.
    Primi MC; Rangarajan ES; Patil DN; Izard T
    Matrix Biol Plus; 2021 Dec; 12():100074. PubMed ID: 34337379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and evaluation of deleterious and disease causing non-synonymous SNPs (nsSNPs) in human NF2 gene responsible for neurofibromatosis type 2 (NF2).
    Havranek B; Islam SM
    J Biomol Struct Dyn; 2021 Nov; 39(18):7044-7055. PubMed ID: 32787631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
    Gutmann DH; Hirbe AC; Haipek CA
    Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants.
    Benseñor LB; Barlan K; Rice SE; Fehon RG; Gelfand VI
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7311-6. PubMed ID: 20368450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function.
    Mori T; Gotoh S; Shirakawa M; Hakoshima T
    Genes Cells; 2014 Aug; 19(8):603-19. PubMed ID: 24912773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation.
    McCartney BM; Kulikauskas RM; LaJeunesse DR; Fehon RG
    Development; 2000 Mar; 127(6):1315-24. PubMed ID: 10683183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
    Laulajainen M; Melikova M; Muranen T; Carpén O; Grönholm M
    J Cell Mol Med; 2012 Sep; 16(9):2161-75. PubMed ID: 22325036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
    Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
    Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.
    Hennigan RF; Fletcher JS; Guard S; Ratner N
    Sci Signal; 2019 Apr; 12(578):. PubMed ID: 31015291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
    Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.